Parallel Advisors, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,528
+1714.0%
313
+2307.7%
0.00%
Q2 2023$415
-76.2%
13
-77.2%
0.00%
Q1 2023$1,745
-89.7%
57
-86.8%
0.00%
-100.0%
Q4 2022$16,935
+746.8%
433
+1039.5%
0.00%
Q3 2022$2,000
+100.0%
38
+58.3%
0.00%
Q2 2022$1,000
-66.7%
24
-46.7%
0.00%
Q1 2022$3,000
-66.7%
45
-57.9%
0.00%
Q4 2021$9,000
+350.0%
107
+463.2%
0.00%
Q3 2021$2,000
+100.0%
19
+90.0%
0.00%
Q2 2021$1,0000.0%100.0%0.00%
Q1 2021$1,0000.0%100.0%0.00%
Q4 2020$1,000100.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders